Abstract:Objective Alteration of mitochondrial dynamics closely links to cellular oxidative stress and inflammation, key risk factors for the development of chronic diseases including obesity and diabetes. Bioactive astaxanthin has been found effective to antioxidation. The purpose of this study is to explore the functional roles of astaxanthin in regulation of mitochondrial dynamics and the consequence in energy metabolism in mice. Methods Six‐week‐old male β, β‐carotene‐9′, 10′‐oxygenase 2 (BCO2) knockout (KO) and the isogenic wild‐type C57BL/6J(WT) mice were fed an astaxanthin supplementation diet (0.04% astaxanthin supplemented to the AIN93‐maintenance diet) or a control diet (AIN93‐maintenance) for 8 weeks, respectively. On the 8 th week of the study, mice were subjected to a phenotyping test. At termination of the study, blood and liver tissues were collected. Plasma metabolic biomarkers were tested, including cholesterol, lipoproteins, triglycerides, nonesterified fatty acids (NEFA), and uric acid. Fresh hepatic mitochondria were isolated and subjected to mitochondrial respiratory function assays. Immunoblotting was performed to determine proteins expression. Results Significant astaxanthin accumulation occurred in BCO2 KO mice. Astaxanthin supplementation significantly decrease the energy expenditure in WT mice, which was abolished by ablation of BCO2, suggesting that proper astaxanthin metabolism is vital to the phenotype. In addition to the astaxanthin‐elevated plasma NEFA levels in both WT and BCO2 KO mice, disruption of astaxanthin metabolism resulted in increases in the plasma levels of C‐reactive protein, total cholesterol, HDL, LDL, triglycerides, and uric acids in BCO2 KO mice. Mitochondrial respiration activity analysis results revealed the increases in basal respiration rate and proton leak in liver of BCO2 KO mice fed astaxanthin, compared to the AIN93 maintenance diet, though no obvious change was found in hepatic mitochondrial respiration in WT mice after astaxanthin treatment. Furthermore, elevated expression of phosphorylation of unc‐51 like autophagy activating kinase 1(ULK1) on Ser757, and uncoupling protein 2, mitofusin 2, and decreased protein levels of p62 and ATG13 indicating potentiated mitophagy and fusion in liver of WT fed the astaxanthin diet. Conclusions Astaxanthin‐potentiated mitophagy and fusion would link to decreased energy expenditure in wild type mice. Disruption of astaxanthin metabolism could be associated with metabolic disorders, including inflammation and dyslipidemia in BCO2 knockout mice.

Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis

Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-κB-mediated inflammation in high fructose and high fat diet-fed mice

Astaxanthin From Haematococcus pluvialis Prevents High-Fat Diet-Induced Hepatic Steatosis and Oxidative Stress in Mice by Gut-Liver Axis Modulating Properties

Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E

Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity

An intervention study in obese mice with astaxanthin, a marine carotenoid--effects on insulin signaling and pro-inflammatory cytokines

PROTECTION OF ASTAXANTHIN AGAINST HIGH-FAT DIET-INDUCED NON-ALCOHOLIC FATTY LIVER DISEASE IN MICE

Astaxanthin inhibits TGF‐β1‐induced fibrogenic gene expression by inhibiting the activation of Smad3 and KLF‐6 pathways in LX‐2 and primary mouse hepatic stellate cells

Xanthophyllomyces dendrorhous-Derived Astaxanthin Regulates Lipid Metabolism and Gut Microbiota in Obese Mice Induced by A High-Fat Diet

Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells

Astaxanthin n-Octanoic Acid Diester Ameliorates Insulin Resistance and Modulates Gut Microbiota in High-Fat and High-Sucrose Diet-Fed Mice

Astaxanthin Mediates Mitochondrial Dynamics in Mice

Effects of astaxanthin in animal models of obesity-associated diseases: A systematic review and meta-analysis

Docosahexaenoic Acid-Acylated Astaxanthin Monoester Ameliorates Chronic High-Fat Diet-Induced Autophagy Dysfunction Via ULK1 Pathway in the Hypothalamus of Mice

Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats

Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet

Astaxanthin, a Marine Carotenoid, Maintains the Tolerance and Integrity of Adipose Tissue and Contributes to Its Healthy Functions

Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.

Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota.

Effect of Astaxanthin on the Inhibition of Lipid Accumulation in 3T3-L1 Adipocytes via Modulation of Lipogenesis and Fatty Acid Transport Pathways